RACHEL LAMBRIGHT: Open Payments
NPI 1649808049 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 13 payments from 4 companies in 2025. Trend: 2023 $138 · 2024 $315 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $157 |
| GENZYME CORPORATION | 1 | $34 |
| Madrigal Pharmaceuticals | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
Products named: RINVOQ, DUPIXENT, SKYRIZI, REZDIFFRA, LINZESS.
Industry payments across MD — which companies pay providers there.
